Wealth Enhancement Advisory Services’s NervGen Pharma NGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.4K Sell
13,365
-3,097
-19% -$5.94K ﹤0.01% 4112
2026
Q2
$30.9K Buy
+16,462
New +$51.1K ﹤0.01% 3988

Other funds holding NGEN

Wealth Enhancement Advisory Services's NGEN Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its NervGen Pharma (NGEN) stake by 19% in Q3 2026, selling an estimated $5.94K and leaving 13,365 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

Wealth Enhancement Advisory Services first reported a position in NGEN in Q2 2026 and has held it in 2 quarters since. The position peaked at $30.9K in Q2 2026. 68 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.

  • Wealth Enhancement Advisory Services held 13,365 shares of NervGen Pharma worth $23.4K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 3,097 NervGen Pharma shares in Q3 2026, an estimated $5.94K.
  • NervGen Pharma made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4112 holding.
  • Wealth Enhancement Advisory Services first reported a position in NervGen Pharma in Q2 2026 and has held it in 2 quarters since.
  • Wealth Enhancement Advisory Services's NervGen Pharma position peaked at $30.9K in Q2 2026.
  • 68 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.